Bitcoin halving
What does that mean?
$2.79T
Total marketcap
$140.97B
Total volume
BTC 49.83%     ETH 15.41%
Dominance

Bayer Aktiengesellschaft BAY.MI Stock

55.5 EUR {{ price }} 0.000000% {{change_pct}}%
COUNTRY
Italy
Exchange
Milan
Market Cap
55.21B EUR
LOW - HIGH [24H]
0.0000 - 0.0000 EUR
VOLUME [24H]
0 EUR
{{ volume }}
P/E Ratio
0
Earnings per share
0 EUR

Bayer Aktiengesellschaft Price Chart

Bayer Aktiengesellschaft BAY.MI Financial and Trading Overview

Bayer Aktiengesellschaft stock price 55.5 EUR
Previous Close 56.5 EUR
Open 55.35 EUR
Bid 0 EUR x 0
Ask 0 EUR x 0
Day's Range 54.86 - 55.53 EUR
52 Week Range 46.77 - 65.63 EUR
Volume 2.28K EUR
Avg. Volume 4.49K EUR
Market Cap 55.02B EUR
Beta (5Y Monthly) 1.15822
PE Ratio (TTM) 13.373493
EPS (TTM) 0 EUR
Forward Dividend & Yield 2.4 (4.25%)
Ex-Dividend Date May 2, 2023
1y Target Est N/A

BAY.MI Valuation Measures

Enterprise Value 86.68B EUR
Trailing P/E 13.373493
Forward P/E 7.0971866
PEG Ratio (5 yr expected) 1.74
Price/Sales (ttm) 1.0842896
Price/Book (mrq) 1.4062382
Enterprise Value/Revenue 1.708
Enterprise Value/EBITDA 6.822

Trading Information

Bayer Aktiengesellschaft Stock Price History

Beta (5Y Monthly) 1.15822
52-Week Change -16.97%
S&P500 52-Week Change 20.43%
52 Week High 65.63 EUR
52 Week Low 46.77 EUR
50-Day Moving Average 56.25 EUR
200-Day Moving Average 54.36 EUR

BAY.MI Share Statistics

Avg. Volume (3 month) 4.49K EUR
Avg. Daily Volume (10-Days) 5.15K EUR
Shares Outstanding 982.42M
Float 982.39M
Short Ratio N/A
% Held by Insiders 0%
% Held by Institutions 42.00%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 2.4
Trailing Annual Dividend Yield 4.24%
5 Year Average Dividend Yield 418.00%
Payout Ratio 0.4739
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) December 31, 2022
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 8.17%
Operating Margin (ttm) 17.97%
Gross Margin 62.77%
EBITDA Margin 25.04%

Management Effectiveness

Return on Assets (ttm) 4.65%
Return on Equity (ttm) 11.55%

Income Statement

Revenue (ttm) 50.74B EUR
Revenue Per Share (ttm) 51.65 EUR
Quarterly Revenue Growth (yoy) 7.90%
Gross Profit (ttm) 31.85B EUR
EBITDA 12.71B EUR
Net Income Avi to Common (ttm) 4.15B EUR
Diluted EPS (ttm) 4.15
Quarterly Earnings Growth (yoy) -47.39%

Balance Sheet

Total Cash (mrq) 10.15B EUR
Total Cash Per Share (mrq) 10.34 EUR
Total Debt (mrq) 41.65B EUR
Total Debt/Equity (mrq) 107 EUR
Current Ratio (mrq) 1.076
Book Value Per Share (mrq) 39.467

Cash Flow Statement

Operating Cash Flow (ttm) 7.09B EUR
Levered Free Cash Flow (ttm) 5.85B EUR

Profile of Bayer Aktiengesellschaft

Country Italy
State N/A
City Leverkusen
Address Kaiser-Wilhelm-Allee 1
ZIP 51368
Phone 49 214 30 1
Website https://www.bayer.com
Industry Drug Manufacturers-General
Sector(s) Healthcare
Full Time Employees 97922

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, and self-care solutions in dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cold and cough. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration agreement with MD Anderson Cancer Center to develop oncology drugs; research and license agreement with Dewpoint Therapeutics, Inc. for the development of new treatments for cardiovascular and gynecological diseases; collaboration agreement with Exscientia Ltd, Foundation Medicine Inc., and Evotec AG; research collaboration with Arvinas Inc.; strategic research partnership with University of Oxford to develop novel gynecological therapies; and Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.

Q&A For Bayer Aktiengesellschaft Stock

What is a current BAY.MI stock price?

Bayer Aktiengesellschaft BAY.MI stock price today per share is 55.5 EUR.

How to purchase Bayer Aktiengesellschaft stock?

You can buy BAY.MI shares on the Milan exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Bayer Aktiengesellschaft?

The stock symbol or ticker of Bayer Aktiengesellschaft is BAY.MI.

Which industry does the Bayer Aktiengesellschaft company belong to?

The Bayer Aktiengesellschaft industry is Drug Manufacturers-General.

How many shares does Bayer Aktiengesellschaft have in circulation?

The max supply of Bayer Aktiengesellschaft shares is 994.86M.

What is Bayer Aktiengesellschaft Price to Earnings Ratio (PE Ratio)?

Bayer Aktiengesellschaft PE Ratio is 0.00000000 now.

What was Bayer Aktiengesellschaft earnings per share over the trailing 12 months (TTM)?

Bayer Aktiengesellschaft EPS is 0 EUR over the trailing 12 months.

Which sector does the Bayer Aktiengesellschaft company belong to?

The Bayer Aktiengesellschaft sector is Healthcare.